Literature DB >> 12629511

Alterations of anaphase-promoting complex genes in human colon cancer cells.

Qing Wang1, Caroline Moyret-Lalle, Florence Couzon, Christine Surbiguet-Clippe, Jean-Christophe Saurin, Thierry Lorca, Claudine Navarro, Alain Puisieux.   

Abstract

Ubiquitin-mediated proteolysis of cell cycle regulators is a major element of the cell cycle control. The anaphase-promoting complex (APC/C) is a large multisubunit ubiquitin-protein ligase required for the ubiquitination and degradation of G1 and mitotic checkpoint regulators. APC/C-dependent proteolysis regulates cyclin levels in G1, and triggers the separation of sister chromatids at the metaphase-anaphase transition and the destruction of mitotic cyclins at the end of mitosis. Furthermore, it was recently shown that APC/C regulates the degradation of crucial regulators of signal transduction pathways. We report here gene alterations in several components of this complex in human colon cancer cells, including APC6/CDC16 and APC8/CDC23 which are known to be key function elements. The experimental expression of a truncation mutant of APC8/CDC23 subunit (CDC23DeltaTPR) leads to abnormal levels of APC/C targets such as cyclin B1 and disturbs the cell cycle progression of colon epithelial cells through mitosis. Overall, these data support the hypothesis of a deleterious role of these mutations during colorectal carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12629511     DOI: 10.1038/sj.onc.1206224

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  47 in total

Review 1.  APC/C ubiquitin ligase: Functions and mechanisms in tumorigenesis.

Authors:  Morgan S Schrock; Benjamin R Stromberg; Luke Scarberry; Matthew K Summers
Journal:  Semin Cancer Biol       Date:  2020-03-09       Impact factor: 15.707

Review 2.  State of the APC/C: organization, function, and structure.

Authors:  Janel R McLean; Denis Chaix; Melanie D Ohi; Kathleen L Gould
Journal:  Crit Rev Biochem Mol Biol       Date:  2011-01-24       Impact factor: 8.250

3.  Antagonists of anaphase-promoting complex (APC)-2-cell cycle and apoptosis regulatory protein (CARP)-1 interaction are novel regulators of cell growth and apoptosis.

Authors:  Vineshkumar Thidil Puliyappadamba; Wenjuan Wu; Debra Bevis; Liyue Zhang; Lisa Polin; Robert Kilkuskie; Russell L Finley; Scott D Larsen; Edi Levi; Fred R Miller; Anil Wali; Arun K Rishi
Journal:  J Biol Chem       Date:  2011-09-08       Impact factor: 5.157

4.  Dose-dependent proteomic analysis of glioblastoma cancer stem cells upon treatment with γ-secretase inhibitor.

Authors:  Lan Dai; Jintang He; Yashu Liu; Jaeman Byun; Anuradha Vivekanandan; Subramaniam Pennathur; Xing Fan; David M Lubman
Journal:  Proteomics       Date:  2011-10-24       Impact factor: 3.984

Review 5.  Functional characterization of Anaphase Promoting Complex/Cyclosome (APC/C) E3 ubiquitin ligases in tumorigenesis.

Authors:  Jinfang Zhang; Lixin Wan; Xiangpeng Dai; Yi Sun; Wenyi Wei
Journal:  Biochim Biophys Acta       Date:  2014-02-22

6.  Flipping the switch from g1 to s phase with e3 ubiquitin ligases.

Authors:  Lindsay F Rizzardi; Jeanette Gowen Cook
Journal:  Genes Cancer       Date:  2012-11

7.  E3 ubiquitin ligase APC/C-Cdh1 accounts for the Warburg effect by linking glycolysis to cell proliferation.

Authors:  Angeles Almeida; Juan P Bolaños; Salvador Moncada
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-22       Impact factor: 11.205

8.  Insights into anaphase promoting complex TPR subdomain assembly from a CDC26-APC6 structure.

Authors:  Jing Wang; Billy T Dye; Kanagalaghatta R Rajashankar; Igor Kurinov; Brenda A Schulman
Journal:  Nat Struct Mol Biol       Date:  2009-08-09       Impact factor: 15.369

Review 9.  When ubiquitin meets NF-κB: a trove for anti-cancer drug development.

Authors:  Zhao-Hui Wu; Yuling Shi
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

10.  Prognostic value of Dicer expression in human breast cancers and association with the mesenchymal phenotype.

Authors:  G Grelier; N Voirin; A-S Ay; D G Cox; S Chabaud; I Treilleux; S Léon-Goddard; R Rimokh; I Mikaelian; C Venoux; A Puisieux; C Lasset; C Moyret-Lalle
Journal:  Br J Cancer       Date:  2009-08-18       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.